Eam Global Investors LLC Replimune Group, Inc. Transaction History

Eam Global Investors LLC

  • $435 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$17.09 - $27.91 $988,092 - $1.61 Million
57,817 New
57,817 $1.57 Million
Q4 2020

Feb 11, 2021
SELL
$23.5 - $52.65 $1.28 Million - $2.86 Million
-54,274 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$18.85 - $27.0 $359,337 - $514,701
-19,063 Reduced 25.99%
54,274 $1.25 Million
Q2 2020

Aug 13, 2020
BUY
$9.76 - $25.95 $715,769 - $1.9 Million
73,337 New
73,337 $1.82 Million

Others Institutions Holding REPL

# of Institutions
149
Shares Held
68M
Call Options Held
52.3K
Put Options Held
80.3K
View Full List

About Replimune Group, Inc.

REPL Quotes by TradingView
  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $694M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email